| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |